Stereotactic ablative radiotherapy (SABR) for hepatocellular carcinoma (adults)

Document first published:
Page updated:
Topic:
Publication type:

Stereotactic ablative radiotherapy (SABR) will be available as a treatment option through routine commissioning for hepatocellular carcinoma in adults within the criteria set out in this document.

Document

Document

Consultation Report

Consultation Report

  • PDF
  • 52 KB
  • 4 pages

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 107 KB
  • 10 pages

Document

Evidence Review

Evidence Review

  • PDF
  • 651 KB
  • 48 pages